首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Synthesis and Antibacterial Evaluation of (SZ)-4-methyl-2-(4-oxo-5-((5-substituted phenylfuran-2-yl) methylene)-2-thioxothiazolidin-3-yl)Pentanoic Acids
【2h】

Synthesis and Antibacterial Evaluation of (SZ)-4-methyl-2-(4-oxo-5-((5-substituted phenylfuran-2-yl) methylene)-2-thioxothiazolidin-3-yl)Pentanoic Acids

机译:(SZ)-4-甲基-2-(4-氧代-5-((5-取代的苯基呋喃-2-基)亚甲基)-2-硫代噻唑烷三-3-基)戊酸的合成及抗菌性能评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The microbial resistance has become a global hazard with the irrational use of antibiotics. Infection of drug-resistant bacteria seriously threatens human health. Currently, there is an urgent need for the development of novel antimicrobial agents with new mechanisms and lower levels of toxicity. In this paper, a series of (S,Z)-4-methyl-2-(4-oxo-5-((5-substitutedphenylfuran-2-yl) methylene)-2-thioxothiazolidin-3-yl)pentanoic acids via a Knoevenagel condensation were synthesized and evaluated for their antibacterial activity in-vitro. The synthesized compounds were characterized by IR, 1H NMR and MS. The antibacterial test in-vitro showed that all of the synthesized compounds had good antibacterial activity against several Gram-positive bacteria (including multidrug-resistant clinical isolates) with minimum inhibitory concentration (MIC) values in the range of 2–4 µg/mL. Especially compounds 4c, 4d, 4e and 4f were the most potent, with MIC values of 2 µg/mL against four multidrug-resistant Gram-positive bacterial strains.
机译:由于不合理使用抗生素,微生物耐药性已成为全球性危害。耐药细菌的感染严重威胁着人类健康。当前,迫切需要开发具有新机理和较低毒性水平的新型抗菌剂。本文研究了一系列(S,Z)-4-甲基-2-(4-氧代-5-((5-取代苯基呋喃-2-基)亚甲基)-2-硫代噻唑烷三-3-基)戊酸合成了Knoevenagel缩合物,并对其体外抗菌活性进行了评估。合成的化合物经IR, 1 NMR和MS表征。体外抗菌测试表明,所有合成的化合物对几种革兰氏阳性细菌(包括耐多药临床分离株)均具有良好的抗菌活性,其最低抑菌浓度(MIC)值在2-4 µg / mL范围内。特别是化合物4c,4d,4e和4f最有效,对四种耐多药革兰氏阳性细菌菌株的MIC值为2 µg / mL。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号